139297-56-6

Basic information

• Product Name: 5-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID
• Synonyms: 5-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID;AKOS PAO-1510;3-Isoxazolecarboxylic acid, 5-(hydroxymethyl)- (9CI);5-(Hydroxymethyl)-1,2-oxazole-3-carboxylic acid
• CAS NO: 139297-56-6
• Molecular Formula: C₅H₅NO₄
• Molecular Weight: 143.1
• Product Categories: ALDEHYDE
• Mol File: 139297-56-6.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID(139297-56-6)
• EPA Substance Registry System: 5-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID(139297-56-6)

Safety Data

• Hazardous Substances Data: 139297-56-6(Hazardous Substances Data)

Usage

General Description

5-(Hydroxymethyl)isoxazole-3-carboxylic acid is a chemical compound with the molecular formula C6H7NO4 and a molar mass of 157.12 g/mol. It is a derivative of isoxazole and contains a hydroxymethyl group and a carboxylic acid group. 5-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID is used in the synthesis of various pharmaceuticals and agrochemicals, and it also has potential applications in the fields of medicine and biochemistry. 5-(Hydroxymethyl)isoxazole-3-carboxylic acid is an important building block in organic synthesis and has been the subject of research for its potential therapeutic properties.

Upstream product

• 123770-62-7 ethyl 5-(hydroxymethyl)isoxazole-3-carboxylate 
• 139297-55-5 methyl 5-(hydroxymethyl)isoxazole-3-carboxylate 

Downstream Products

• 80173-68-8 5-(chloromethyl)-3-isoxazolecarbonyl chloride 
• 139297-39-5 N-(2,6-dimethylphenyl)-5-fluoromethyl-3-isoxazolecarboxamide 
• 130403-18-8 D₃₀₁₇ 
• 139297-37-3 N-(2,6-dimethylphenyl)-5-benzoyloxymethyl-3-isoxazolecarboxamide 
• 130403-23-5 3-(2,6-dimethyl phenyl carbamoyl)-5-acetoxymethyl isoxazole 
• 833445-84-4 3-allyloxycarbonyl-5-bromomethylisoxazole 

Relevant articles and documents

INHIBITORS OF PDE6DELTA FOR USE IN THE PREVENTION AND/OR TREATMENT OF EPILEPSY AND/OR NEURODEGENERATIVE DISORDERS

The present provides compounds and methods for preventing and/or treating epilepsy and/or neurodegenerative disorders. More particularly, the invention provides inhibitors of PDE6δ for use in the prevention and/or treatment of neurodegenerative disorders and/or epilepsy.

PHTHALAZINE DERIVATIVES, AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF

The present invention provides a compound of formula I, a cis-trans isomer, an enantiomer, a diastereoisomer, a racemate, a solvate, a hydrate, or a pharmaceutical acceptable salt and ester thereof, a preparation method for preparing the same, a pharmaceutical composition comprising the same and a use of the compound as an α5-GABAA receptor regulator, wherein T, Z, A and Y are as defined in the description.

INDOLE AMIDE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES

This invention provides novel compounds and the novel compounds for use as a medicine, more in particular for the prevention or treatment of neurodegenerative disorders, more specifically certain neurological disorders, such as disorders collectively known as tauopathies, and disorders characterised by cytotoxic α-synuclein amyloidogenesis. The present invention also relates to the use of said novel compounds for the manufacture of medicaments useful for treating such neurodegenerative disorders. The present invention further relates to pharmaceutical compositions including said novel compounds and to methods for the preparation of said novel compounds.